{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:26:51Z","timestamp":1791570411588,"version":"4.3.4"},"reference-count":68,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sickle cell nephropathy results in chronic kidney disease (CKD), which is associated with significant morbidity and mortality in sickle cell anemia (SCA). Albuminuria is an early manifestation of sickle nephropathy; however, little is known about progression of albuminuria or its correlation with glomerular filtration rate (GFR) decline or CKD. We studied nephropathy progression in 303 SCA participants in a prospective, multicenter, longitudinal study. We collected steady-state urine and serum samples yearly and assessed albumin\/creatinine ratio (ACR), estimated GFR (eGFR), and SCA and nephropathy biomarkers. Participants with albuminuria (ACR \u226530 mg\/g) for \u22652 annual measurements were classified as having persistent albuminuria (PA). At baseline (mean age, 21 years; range, 2-64 years), 32% had albuminuria. In longitudinal multivariate analysis, ACR was associated with sex, anemia, older age, and higher bilirubin and kidney injury molecule-1 levels. Albuminuria increased with age by 3.5 mg\/g per year (P &amp;lt; .0001). Of 175 participants with \u22653 annual samples, 81% with baseline albuminuria \u2265100 mg\/g developed PA. Decreased eGFR and adult CKD were associated with PA (P = .002 and P = .02, respectively), but not with baseline albuminuria. Rate of eGFR decline was steeper among adults (but not children) with albuminuria, compared with those without (P = .02). Participants with PA were more likely to have rapid eGFR decline compared with those without (P = .03). In this longitudinal study, albuminuria progressed with age, and adults with albuminuria had worse eGFR decline than those without. Albuminuria \u2265100 mg\/g predicted PA, which was associated with rapid eGFR decline and CKD development in adults with SCA. This trial was registered at www.clinicaltrials.gov as #NCT02239016.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001378","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T11:38:30Z","timestamp":1586864310000},"page":"1501-1511","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-4644","authenticated-orcid":false,"given":"Omar","family":"Niss","sequence":"first","affiliation":[{"name":"Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Bone Marrow Transplantation, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7184-138X","authenticated-orcid":false,"given":"Monika R.","family":"Asnani","sequence":"first","affiliation":[{"name":"Sickle Cell Unit, Caribbean Institute for Health Research, University of the West Indies, Kingston, Jamaica;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6082-8385","authenticated-orcid":false,"given":"Marianne E.","family":"Yee","sequence":"first","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, GA;"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Raj","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Louisville, Louisville, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Creary","sequence":"first","affiliation":[{"name":"Center for Innovation in Pediatric Practice, Division of Pediatric Hematology\/Oncology\/BMT, Nationwide Children\u2019s Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Fitzhugh","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Bodas","sequence":"first","affiliation":[{"name":"Akron Children\u2019s Hospital, Akron, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-4194","authenticated-orcid":false,"given":"Santosh L.","family":"Saraf","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharada","family":"Sarnaik","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Detroit, MI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Devarajan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punam","family":"Malik","sequence":"first","affiliation":[{"name":"Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"},{"name":"Division of Experimental Hematology and Cancer Biology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"issue":"3","key":"2020041411382115000_B1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"2020041411382115000_B2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"2020041411382115000_B3","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2020041411382115000_B4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000167444","article-title":"Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study","volume":"7","author":"Bakir","year":"1987","journal-title":"Am J Nephrol"},{"issue":"5","key":"2020041411382115000_B5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.JIM.0000446836.75352.72","article-title":"Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease","volume":"62","author":"Gosmanova","year":"2014","journal-title":"J Investig Med"},{"issue":"9","key":"2020041411382115000_B6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ajh.23762","article-title":"The glomerulopathy of sickle cell disease","volume":"89","author":"Ataga","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"2020041411382115000_B7","doi-asserted-by":"crossref","first-page":"e26993","DOI":"10.1002\/pbc.26993","article-title":"Nephrin as a biomarker of sickle cell glomerulopathy in Malawi","volume":"65","author":"Heimlich","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2020041411382115000_B8","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2215\/CJN.01600211","article-title":"Chronic kidney disease and albuminuria in children with sickle cell disease","volume":"6","author":"McPherson Yee","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2020041411382115000_B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03630269.2016.1224766","article-title":"Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay","volume":"40","author":"Yeruva","year":"2016","journal-title":"Hemoglobin"},{"issue":"1","key":"2020041411382115000_B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CNP58009","article-title":"Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"58","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"issue":"8","key":"2020041411382115000_B11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality","volume":"115","author":"Powars","year":"1991","journal-title":"Ann Intern Med"},{"issue":"3","key":"2020041411382115000_B12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"issue":"11","key":"2020041411382115000_B13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.V1111241","article-title":"The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis","volume":"1","author":"Bhathena","year":"1991","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2020041411382115000_B14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","article-title":"Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial","volume":"156","author":"Ware","year":"2010","journal-title":"J Pediatr"},{"issue":"7","key":"2020041411382115000_B15","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1002\/ajh.25118","article-title":"Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy","volume":"93","author":"Roy","year":"2018","journal-title":"Am J Hematol"},{"issue":"9","key":"2020041411382115000_B16","doi-asserted-by":"crossref","first-page":"E520","DOI":"10.1002\/ajh.24810","article-title":"Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial","volume":"92","author":"Quinn","year":"2017","journal-title":"Am J Hematol"},{"issue":"8","key":"2020041411382115000_B17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"2020041411382115000_B18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.ajkd.2013.06.016","article-title":"Day-to-day variability in spot urine albumin-creatinine ratio","volume":"62","author":"Naresh","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2020041411382115000_B19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0272-6386(03)00826-6","article-title":"Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2020041411382115000_B20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","article-title":"Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE)","volume":"105","author":"Hogg","year":"2000","journal-title":"Pediatrics"},{"issue":"5","key":"2020041411382115000_B21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","article-title":"Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation","volume":"33","author":"Keane","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2020041411382115000_B22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fped.2016.00106","article-title":"Changes in urine microalbumin-to-creatinine ratio in children with sickle cell disease over time","volume":"4","author":"Shatat","year":"2016","journal-title":"Front Pediatr"},{"issue":"1","key":"2020041411382115000_B23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2018.12.027","article-title":"Progressive decline in estimated GFR in patients with sickle cell disease: an observational cohort study","volume":"74","author":"Derebail","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2020041411382115000_B24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcmd.2017.09.006","article-title":"Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia","volume":"69","author":"Yee","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2020041411382115000_B25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.25390","article-title":"Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy","volume":"94","author":"Lebensburger","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"2020041411382115000_B26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"2020041411382115000_B27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2020041411382115000_B28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020041411382115000_B29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","article-title":"Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature","volume":"5","author":"Haymann","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2020041411382115000_B30","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ajh.23817","article-title":"Hyperfiltration is associated with the development of microalbuminuria in patients with sickle cell anemia","volume":"89","author":"Vazquez","year":"2014","journal-title":"Am J Hematol"},{"issue":"2","key":"2020041411382115000_B31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.ajkd.2013.01.012","article-title":"Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"62","author":"Peralta","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2020041411382115000_B32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ajh.25263","article-title":"Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease","volume":"93","author":"Xu","year":"2018","journal-title":"Am J Hematol"},{"issue":"2","key":"2020041411382115000_B33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2016.02.046","article-title":"Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS)","volume":"68","author":"Young","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2020041411382115000_B34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: definition and classification of CKD","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"issue":"6","key":"2020041411382115000_B35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/02664763.2016.1193725","article-title":"An R2 statistic for fixed effects in the generalized linear mixed model","volume":"44","author":"Jaeger","year":"2017","journal-title":"J Appl Stat"},{"issue":"1","key":"2020041411382115000_B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","article-title":"Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency","volume":"83","author":"Gordeuk","year":"2008","journal-title":"Am J Hematol"},{"issue":"6","key":"2020041411382115000_B37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/pbc.21520","article-title":"Short-term follow-up of patients with sickle cell disease and albuminuria","volume":"50","author":"Alvarez","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2020041411382115000_B38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPH.0b013e3180335081","article-title":"Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease","volume":"29","author":"McKie","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"2020041411382115000_B39","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/ndt\/gfv121","article-title":"Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes","volume":"30","author":"Bjornstad","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2020041411382115000_B40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2183\/pjab.93.046","article-title":"One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes","volume":"93","author":"Nojima","year":"2017","journal-title":"Proc Jpn Acad, Ser B, Phys Biol Sci"},{"issue":"20","key":"2020041411382115000_B41","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/archinte.168.20.2212","article-title":"Rapid kidney function decline and mortality risk in older adults","volume":"168","author":"Rifkin","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6","key":"2020041411382115000_B42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2020041411382115000_B43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"2020041411382115000_B44","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2016.154153","article-title":"APOL1, \u03b1-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia","volume":"102","author":"Saraf","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"2020041411382115000_B45","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.3324\/haematol.2018.212779","article-title":"Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life","volume":"104","author":"Zahr","year":"2019","journal-title":"Haematologica"},{"issue":"7","key":"2020041411382115000_B46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/pbc.20296","article-title":"Enalapril and hydroxyurea therapy for children with sickle nephropathy","volume":"45","author":"Fitzhugh","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2020041411382115000_B47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/bjh.14969","article-title":"Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients","volume":"179","author":"Haymann","year":"2017","journal-title":"Br J Haematol"},{"issue":"5","key":"2020041411382115000_B48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0002-9343(99)80341-6","article-title":"Enalapril reduces the albuminuria of patients with sickle cell disease","volume":"98","author":"Aoki","year":"1995","journal-title":"Am J Med"},{"issue":"4","key":"2020041411382115000_B49","doi-asserted-by":"crossref","first-page":"e18863","DOI":"10.1371\/journal.pone.0018863","article-title":"Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease","volume":"6","author":"Asnani","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"2020041411382115000_B50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am J Hematol"},{"issue":"14","key":"2020041411382115000_B51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","article-title":"Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme","volume":"326","author":"Falk","year":"1992","journal-title":"N Engl J Med"},{"issue":"8","key":"2020041411382115000_B52","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2020041411382115000_B53","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00467-010-1560-8","article-title":"Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia","volume":"25","author":"Gurkan","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2020041411382115000_B54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.21058","article-title":"Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes","volume":"83","author":"De Castro","year":"2008","journal-title":"Am J Hematol"},{"issue":"10","key":"2020041411382115000_B55","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2020041411382115000_B56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03940415","article-title":"Kidney disease among patients with sickle cell disease, hemoglobin SS and SC","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2020041411382115000_B57","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","article-title":"Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease","volume":"29","author":"Laurin","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2020041411382115000_B58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia","volume":"59","author":"Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2020041411382115000_B59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","article-title":"Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia","volume":"88","author":"Aygun","year":"2013","journal-title":"Am J Hematol"},{"issue":"1","key":"2020041411382115000_B60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.20645","article-title":"Early blood transfusions protect against microalbuminuria in children with sickle cell disease","volume":"47","author":"Alvarez","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2020041411382115000_B61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2011.050336","article-title":"Association between hemolysis and albuminuria in adults with sickle cell anemia","volume":"97","author":"Day","year":"2012","journal-title":"Haematologica"},{"issue":"3","key":"2020041411382115000_B62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0609.2010.01471.x","article-title":"Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1","volume":"85","author":"Ataga","year":"2010","journal-title":"Eur J Haematol"},{"issue":"10","key":"2020041411382115000_B63","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00467-014-2821-8","article-title":"Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia","volume":"29","author":"Hamideh","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"2020041411382115000_B64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ajh.22045","article-title":"Biomarkers for early detection of sickle nephropathy","volume":"86","author":"Sundaram","year":"2011","journal-title":"Am J Hematol"},{"issue":"4","key":"2020041411382115000_B65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/08880018.2013.810317","article-title":"Cystatin C, beta2 microglobulin, N-acetyl-beta-D-glucosaminidase, retinol-binding protein, and endothelin 1 levels in the evaluation of sickle cell disease nephropathy","volume":"32","author":"Unal","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"issue":"11","key":"2020041411382115000_B66","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.ki.5000248","article-title":"Early markers of renal dysfunction in patients with sickle cell\/beta-thalassemia","volume":"69","author":"Voskaridou","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"2020041411382115000_B67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2020041411382115000_B68","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-90-3-310","article-title":"Impaired renal tubular potassium secretion in sickle cell disease","volume":"90","author":"DeFronzo","year":"1979","journal-title":"Ann Intern Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/7\/1501\/1724304\/advancesadv2019001378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/7\/1501\/1724304\/advancesadv2019001378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T03:37:16Z","timestamp":1666323436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/7\/1501\/454373\/Progression-of-albuminuria-in-patients-with-sickle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001378","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]}}}